Our Pipeline and Products

Menarini is investing in advanced science and technology to develop a pipeline of new products that make a difference to the lives of patients affected by serious conditions.

MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.

Share your partnering idea

Our dedicated Corporate Business Development team is committed to assess and explore innovative new opportunities.

 

Donations of backpacks and cases for school, distribution of meals and medicines, promotion of sport, support for pregnant women and much more: being responsible for Menarini means transforming good intentions into concrete efforts. By helping others, we want to contribute to improve the world around us, starting with us.

Our Values

Everyday we put our values into action. 4 values, which have given life to Menarini and shaped its history.

 

What does it really make Menarini unique? The diversity and authenticity of our key resource - the People.
Our cultural diversity helps us to drive innovation, adapt to business changes, face challenges, inspire ideas and develop our growth.

Available positions on Linkedin

Menarini employees make all the difference, every day.

 

News

EAS

2025/05/04-2025/05/07

Glasgow

The 93rd European Atherosclerosis Society (EAS) Congress will be held in Glasgow, Scotland from May 4-7, 2025. This congress focuses on atherosclerosis and related vascular diseases, covering the latest research from basic science to clinical trials and its impact on diagnosis and treatment. It's designed for clinicians and basic researchers working in the field. The congress offers a high-level scientific program featuring world-leading experts, including the Anitschkow Lecture, Keynote Lectures, Plenary Sessions, Workshops, and Clinical Seminars. Attendees will have opportunities for networking and collaboration. The EAS is committed to supporting young investigators through fellowships and presentations. The congress will have both in-person and virtual attendance options. It's a major international conference for anyone involved in atherosclerosis research and clinical practice, with a strong emphasis on in-person interaction to drive progress in the field.

DATE

2025/05/04-2025/05/07

LOCATION

Glasgow

THERAPEUTIC AREAS

SPONSORSHIP

-

DOWNLOAD

-

WHERE TO FIND US

-